Examines the role of oral hypoglycemic drugs in the type 2 diabetic patient with end-stage renal disease (ESRD). First-line therapy for patients with type 2 diabetes; Causes of type 2 diabetes; Glucoregulatory dysfunction in type 2 diabetic with ESRD; Four classes of oral hypoglycemic agents that are useful in type 2 diabetics.